Gastroenterology Xagena

Xagena Mappa
Xagena Newsletter
Medical Meeting

Search results for "Stivarga"

Bayer HealthCare has announced that the European Commission has approved Stivarga ( Regorafenib ) tablets for the treatment of adult patients with metastatic colorectal cancer ( mCRC ) who have previo ...

Metastatic colorectal cancer ( mCRC ) is commonly treated with 5-Fluorouracil, Folinic acid, and Oxaliplatin or Irinotecan. The multitargeted kinase inhibitor, Regorafenib ( Stivarga ), was combined ...